$20.550
-0.882 (-4.29%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de MLYS por análisis de gráficos similares
Alphio's MLYS stock price prediction model matches the current Mineralys Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $20.44 (-0.52%). The 1-week path is $20.58 (+0.15%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Mineralys Therapeutics Inc?
Currently, Mineralys Therapeutics Inc (MLYS) is not a strong buy due to its significant recent losses and negative technical indicators. The stock is trading at $20.55, which is down 42.45% year-to-date and 49.33% over the past year. The RSI is at 36.371, indicating it is nearing oversold territory, but the MACD shows a bearish trend with a value of -1.431. The company has posted substantial losses, with a net income of -241 million in Q2 2026, and a forward P/E ratio of 0 suggests uncertainty in future earnings. The main risk is the company's declining equity, which dropped to $550 million in Q2 2026 from $646 million in Q4 2025. Given these factors, it may be prudent to hold off on buying until there are clearer signs of recovery and improved financial performance.
MLYS cerró en $20.55 el Friday, tras bajar -4.29%
Mineralys Therapeutics Inc (MLYS) last closed at $20.55, losing -4.29%. These facts feed the 1-day and 1-week MLYS price prediction above.
Factores de la previsión
Los factores de la previsión de Mineralys Therapeutics Inc (MLYS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de MLYS, ordenadas por similitud.
Análisis de estacionalidad de MLYS
Historically the probability of a positive October return for MLYS is 73.02%. November offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de MLYS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $9.73 | $12.70 | $15.05 | -38.20% |
| Nov 2026 | $13.39 | $16.61 | $19.53 | -19.15% |
| Dec 2026 | $17.09 | $17.18 | $20.56 | -16.39% |
En 2026, se proyecta que Mineralys Therapeutics Inc (MLYS) oscile entre $9.73 y $20.56.
Previsión mensual de Mineralys Therapeutics Inc para 2026
En Oct de 2026, se proyecta que Mineralys Therapeutics Inc promedie $12.70, con un mínimo de $9.73 y un máximo de $15.05.
En Nov de 2026, se proyecta que Mineralys Therapeutics Inc promedie $16.61, con un mínimo de $13.39 y un máximo de $19.53.
En Dec de 2026, se proyecta que Mineralys Therapeutics Inc promedie $17.18, con un mínimo de $17.09 y un máximo de $20.56.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.